Ocera Therapeutics, Inc. announces top-line results from its exploratory STOP-HE Phase 2b Study evaluating the efficacy, safety and tolerability of intravenousl [...]
About emmaadminThis author has not yet filled in any details.
So far emmaadmin has created 306 blog entries.
Intract Pharma and Finch Therapeutics announce collaboration to enable targeted delivery of microbial communitiesemmaadmin2017-10-03T09:29:30+01:00
Intract Pharma, an oral drug delivery spinout company from UCL School of Pharmacy and Finch Therapeutics, Inc., a microbiome therapeutics company based in Somer [...]
The UCL Technology Fund (UCLTF), which provides funding and support for UCL’s most transformative innovations, has approved an investment of up to £1m in Profes [...]
A drug which is used to treat the common eye disease glaucoma may have potential as a treatment for Alzheimer’s disease, according to scientists at UCL. In tria [...]
Two-dimensional (2D) nanomaterials have been made by dissolving layered materials in liquids, according to new UCL-led research. The liquids can be used to appl [...]
Sir Simon Campbell CBE FRS FMedSci was welcomed by staff, and guests when he officially opened The Domainex Medicines Research Centre on Friday 11th November. T [...]
A breakthrough treatment for liver disease could offer hope to the millions worldwide who suffer from the illness and reduce the annual UK toll of 13,000 deaths [...]
During today’s Nature Webinar, Professor Julie Daniels of UCL Institute of Ophthalmology explained how her laboratory has successfully developed multilayer corn [...]
UCLB spin-out companies will be at the heart of a new £1 billion life sciences company which has been created by three major investors in cancer research and ot [...]
Insurers now have an easy way to access, visualise, and analyse European windstorm data from UCLB spinout company EuroTempest, to help them proactively manage r [...]